We are live on ! Find out more
FLNA

Filana Therapeutics

68 hedge funds and large institutions have $77.4M invested in Filana Therapeutics in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

326% more capital invested

Capital invested by funds: $18.2M → $77.4M (+$59.3M)

83% more call options, than puts

Call options by funds: $7.35M | Put options by funds: $4.01M

33% more funds holding

Funds holding: 5168 (+17)

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

3.16% more ownership

Funds ownership: 24.19%27.35% (+3.2%)

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
1.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
22
Increased
19
Reduced
15
Closed
5
Calls
$7.35M
Puts
$4.01M
Net Calls
+$3.34M
Net Calls Change
+$2.43M
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$386K +$20K +4,440 +15%
SC
27
Sculptor Capital
New York
$349K +$137K +30,300 New
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$331K
Citadel Advisors
29
Citadel Advisors
Florida
$327K -$427K -94,660 -77%
N
30
Nuveen
North Carolina
$304K -$146K -32,320 -26%
SWP
31
Stratos Wealth Partners
Ohio
$281K +$110K +24,433 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$264K +$4.16K +923 +4%
TRCT
33
Tower Research Capital (TRC)
New York
$259K +$96.3K +21,362 +1,856%
CSS
34
Cubist Systematic Strategies
Connecticut
$256K +$100K +22,200 New
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$241K -$52.7K -11,700 -36%
Marshall Wace
36
Marshall Wace
United Kingdom
$230K +$89.9K +19,940 New
IC
37
Intersect Capital
California
$230K +$90.2K +20,000 New
Osaic Holdings
38
Osaic Holdings
Arizona
$229K +$68.3K +15,157 +319%
CAN
39
Cetera Advisor Networks
California
$189K +$11.1K +2,460 +18%
AAS
40
Avantax Advisory Services
Texas
$183K +$71K +15,750 New
SFI
41
Susquehanna Fundamental Investments
Pennsylvania
$167K
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$164K
AIG
43
American International Group
New York
$160K -$1.42K -315 -2%
Jane Street
44
Jane Street
New York
$158K -$366K -81,222 -86%
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$153K +$59.8K +13,262 New
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$151K
Goldman Sachs
47
Goldman Sachs
New York
$144K +$56.5K +12,543 New
Deutsche Bank
48
Deutsche Bank
Germany
$136K +$5.07K +1,124 +11%
Barclays
49
Barclays
United Kingdom
$122K -$83.9K -18,602 -64%
JP Morgan Chase
50
JP Morgan Chase
New York
$99K +$3.81K +845 +11%

FLNA Hedge Fund Activity: Q3 2020 in Review

68 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2020, worth a combined $77.4M — up 326% from $18.2M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FLNA positions and 5 closed out — a net gain of 17 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $1.3M. The largest seller was Bleichroeder LP, cutting an estimated $1.65M.

  • 68 institutional investors held Filana Therapeutics (FLNA) as of Q3 2020, up from 51 in Q2 2020.
  • Funds reported $77.4M of Filana Therapeutics stock for Q3 2020, up 326% quarter-over-quarter.
  • 22 funds opened new Filana Therapeutics positions in Q3 2020 and 5 closed out, a net change of +17 holders.
  • The largest Filana Therapeutics buyer in Q3 2020 was ExodusPoint Capital Management, an estimated $1.3M added.
  • The largest Filana Therapeutics seller in Q3 2020 was Bleichroeder LP, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2020.